GILD241108C65000
- 0.00
- 0.000.00%
Gilead Sciences Newsroom
Arcus Says Gilead-partnered Cancer Therapy Cut Death Risk by 36%
Arcellx Issues Updates on Anito-cel Clinical Trials
Gilead's Kite To Highlight CAR T-Cell Therapy Portfolio At ASH 2024, Including Survival Outcomes In Both Clinical Trials And The Real-World
Express News | Kite to Highlight Industry-Leading Car T-Cell Therapy Portfolio at Ash 2024, Including Positive Survival Outcomes in Both Clinical Trials and the Real-World
Gilead Sciences's Earnings: A Preview
Is Gilead Sciences, Inc. (GILD) the Best Pharma Stock to Buy Right Now?
Gilead Science to Report Q3 Earnings: What's in the Cards?
Gilead Sciences Hits 8-1/2-year High
Jefferies Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $105
Jefferies Remains a Buy on Gilead Sciences (GILD)
US Equity Investors to Look Out for Presidential Election Results, Fed Rate Cut, Quarterly Earnings This Week
Nvidia, Apple, Sherwin-Williams, DJT, Viking Therapeutics, Talen Energy, and More Stock Market Movers
Earnings Week Ahead: O, PLTR, QCOM, SQ, AMC, PARA, LCID, RIVN, WBD, and More
Express News | JEFFERIES: Raised Gilead's target price from $95 to $105.
Express News | Gilead : Jefferies Raises Target Price to $105 From $95
Super Micro, Ferrari, Marriott, Airbnb, Novo Nordisk, and More Stocks to Watch This Week
Earnings Preview: GILD to Report Financial Results Post-market on November 06
$Gilead Sciences(GILD.US)$ is scheduled to release its financial results post-market on November 06 ET. Earnings PreviewAnalysts estimate $Gilead Sciences(GILD.US)$ to post revenue of USD7.00B for 202
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
Retail Resilience: Kontoor Brands Rallies to an All-time High After Better-than-expected Earnings
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It